Literature DB >> 12795360

Three-peptide control of pulsatile and entropic feedback-sensitive modes of growth hormone secretion: modulation by estrogen and aromatizable androgen.

Johannes D Veldhuis1, Cyril Y Bowers.   

Abstract

The present review highlights a simplified perspective of growth hormone (GH) secretory control, which incorporates the individual and joint effects of final-common signals that converge on somatotrope cells. Critical peptidyl effectors are GH-releasing hormone (GHRH), GH-releasing peptide (GHRP, ghrelin), and somatostatin. The latter three-peptide ensemble mediates stimulation, inhibition, and feedback suppression of GH secretion via homologous and heterologous interactions. Pubertal sex steroids putatively act via post-aromatized estrogen (e.g., testosterone converted to estradiol by aromatase) to augment sensitivity to GHRH, potentiate GHRP action, and mute somatostatin restraint. The dynamic interactions in this three-peptide network, rather than the activity of any single effector, subserve core adaptations in GH secretion across development.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12795360

Source DB:  PubMed          Journal:  J Pediatr Endocrinol Metab        ISSN: 0334-018X            Impact factor:   1.634


  13 in total

Review 1.  Ageing, growth hormone and physical performance.

Authors:  F Lanfranco; L Gianotti; R Giordano; M Pellegrino; M Maccario; E Arvat
Journal:  J Endocrinol Invest       Date:  2003-09       Impact factor: 4.256

Review 2.  Impact of growth plate senescence on catch-up growth and epiphyseal fusion.

Authors:  Ola Nilsson; Jeffrey Baron
Journal:  Pediatr Nephrol       Date:  2005-01-27       Impact factor: 3.714

3.  Determinants of dual secretagogue drive of burst-like growth hormone secretion in premenopausal women studied under a selective estradiol clamp.

Authors:  Dana Erickson; Daniel M Keenan; Leon Farhy; Kristi Mielke; Cyril Y Bowers; Johannes D Veldhuis
Journal:  J Clin Endocrinol Metab       Date:  2004-12-21       Impact factor: 5.958

4.  Gender modulates sequential suppression and recovery of pulsatile growth hormone secretion by physiological feedback signals in young adults.

Authors:  Johannes D Veldhuis; Leon Farhy; Arthur L Weltman; Jonathan Kuipers; Judith Weltman; Laurie Wideman
Journal:  J Clin Endocrinol Metab       Date:  2005-02-22       Impact factor: 5.958

5.  Plasma ghrelin responses to acute sculling exercises in elite male rowers.

Authors:  Jaak Jürimäe; Peter Hofmann; Toivo Jürimäe; Reet Palm; Jarek Mäestu; Priit Purge; Karl Sudi; Klaus Rom; Serge P von Duvillard
Journal:  Eur J Appl Physiol       Date:  2006-12-22       Impact factor: 3.078

6.  The negative association between plasma ghrelin and IGF-I is modified by obesity, insulin resistance and type 2 diabetes.

Authors:  S M Pöykkö; O Ukkola; H Kauma; E Kellokoski; S Hörkkö; Y A Kesäniemi
Journal:  Diabetologia       Date:  2005-02-02       Impact factor: 10.122

7.  The effect of 17β-estradiol on sex-dimorphic cytochrome P450 expression patterns induced by hyperoxia in the liver of male CBA/H mice.

Authors:  Željka Mačak Šafranko; Tihomir Balog; Marina Musa; Ivana Tartaro Bujak; Sandra Sobočanec
Journal:  Mol Cell Biochem       Date:  2016-08-31       Impact factor: 3.396

Review 8.  Mechanisms of growth impairment in pediatric Crohn's disease.

Authors:  Thomas D Walters; Anne M Griffiths
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2009-09       Impact factor: 46.802

9.  Hormone secretion by pituitary adenomas is characterized by increased disorderliness and spikiness but more regular pulsing.

Authors:  Ferdinand Roelfsema; Alberto M Pereira; Nienke R Biermasz; Johannes D Veldhuis
Journal:  J Clin Endocrinol Metab       Date:  2014-07-11       Impact factor: 5.958

10.  Relative effects of estrogen, age, and visceral fat on pulsatile growth hormone secretion in healthy women.

Authors:  Johannes D Veldhuis; Susan B Hudson; Dana Erickson; Joy N Bailey; George Ann Reynolds; Cyril Y Bowers
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-05-26       Impact factor: 4.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.